BioHealth News

CinCor Pharma to be Acquired by AstraZeneca

CinCor Pharma to be Acquired by AstraZeneca

WALTHAM, Mass., Jan. 09, 2023 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (NASDAQ: CINC) today announced that it has entered into a definitive agreement with…

Read More

Gaithersburg’s Novavax names John Jacobs as new CEO – Washington Business Journal

The transition will take place in late January. Image: Stanley Erck is retiring as CEO of Gaithersburg vaccine maker Novavax. EMAN MOHAMMED {iframe}https://www.bizjournals.com/washington/news/2023/01/09/novavax-stanley-erck-john-jacobs-ceo-covid-vaccine.html?utm_source=st&utm_medium=en&utm_campaign=BN&utm_content=wa&ana=e_wa_BN&j=30194551&senddate=2023-01-09{/iframe}

Read More
AstraZeneca to Aquire CinCor Pharma, Inc

AstraZeneca to Aquire CinCor Pharma, Inc

Today we announced an agreement to acquire CinCor Pharma, Inc., a US-based clinical-stage biopharmaceutical company, focused on developing novel treatments for resistant and uncontrolled…

Read More
Qiagen acquires DNA-biometrics firm Verogen in $150 mln deal

Qiagen acquires DNA-biometrics firm Verogen in $150 mln deal

Jan 9 (Reuters) - Life sciences firm Qiagen said on Monday it has acquired DNA-biometrics firm Verogen in a $150-million cash deal, strengthening its…

Read More
Technology as a New Evolution in Fighting Disease

Technology as a New Evolution in Fighting Disease

Scientists and researchers have made remarkable breakthroughs in basic science to better understand the complex pathology of many diseases today. Some of that progress…

Read More
NIH-Oxford Scholar Sooraj Achar Honored with BioHealth Innovation Award – International Biomedical Alliance

NIH-Oxford Scholar Sooraj Achar Honored with BioHealth Innovation Award – International Biomedical Alliance

First awarded in 2016, the International Biomedical Research Alliance’s Innovation Award recognizes novel solutions in biology or medicine and acknowledges discoveries of unusual importance,…

Read More
Emergent BioSolutions Awarded $379.6 Million Procurement Contract to Supply RSDL© (Reactive Skin Decontamination Lotion Kit) to U.S. Department of Defense

Emergent BioSolutions Awarded $379.6 Million Procurement Contract to Supply RSDL© (Reactive Skin Decontamination Lotion Kit) to U.S. Department of Defense

GAITHERSBURG, Md., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has signed an indefinite-delivery, indefinite-quantity procurement contract with a…

Read More
Who were the biggest employers in Maryland last year?

Who were the biggest employers in Maryland last year?

Maryland, with its six million plus residents, may not be the biggest state, but even before the creation of the United States, the colony’s…

Read More
What’s next for mRNA vaccines | MIT Technology Review

What’s next for mRNA vaccines | MIT Technology Review

Cast your mind back to 2020, if you can bear it. As the year progressed, so did the impact of covid-19. We were warned…

Read More
WuXi Biologics and GSK Enter into License Agreement on Multiple Novel Bi- & Multi-specific T Cell Engagers

WuXi Biologics and GSK Enter into License Agreement on Multiple Novel Bi- & Multi-specific T Cell Engagers

SHANGHAI, Jan. 4, 2023 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced…

Read More
Life Sciences Real Estate 2023: Resolutions And Recalibration For A Cautious Year Ahead

Life Sciences Real Estate 2023: Resolutions And Recalibration For A Cautious Year Ahead

Looking forward to the trends that will define the new year, and predictions for 2023, a group of leading life sciences industry analysts predicted…

Read More
NeoImmuneTech to Partner with U.S. National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) for Drug Development in Acute Radiation Syndrome (ARS)

NeoImmuneTech to Partner with U.S. National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) for Drug Development in Acute Radiation Syndrome (ARS)

ROCKVILLE, Md., Jan. 3, 2023 /PRNewswire/ -- NeoImmuneTech, Inc. (NIT or "NeoImmuneTech"), a clinical-stage T cell-focused biopharmaceutical company, today announced an agreement with the National Institute…

Read More
Matt Honan Joins Emmes as Vice President and Head of Corporate Development

Matt Honan Joins Emmes as Vice President and Head of Corporate Development

ROCKVILLE, Md., Jan. 4, 2023 /PRNewswire/ -- Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and…

Read More
Meet The Daily Record’s Power 100 | Maryland Daily Record

Meet The Daily Record’s Power 100 | Maryland Daily Record

For the second year in a row, we offer readers a look at the 100 men and women who are shaping our businesses, governments,…

Read More
Ric Hughen CEO of Linshom Medical, Visits the BioTalk Podcast

Ric Hughen CEO of Linshom Medical, Visits the BioTalk Podcast

Linshom Medical CEO, Ric Hughen, joins Rich Bendis on BioTalk to discuss his career, their respiratory monitor, and growing a company in the BioHealth…

Read More